Blogs

Explore our latest pharmaceutical and healthcare blogs for expert perspectives, strategic insights, and emerging trends across R&D, market access, digital health, and regulatory science—curated to inform, inspire, and empower your next move.

Subscribe for Latest Updates
EU Pharmaceutical Supply Chain How to Shrink Upstream Risk Without Shrinking Access
November 11, 2025

EU Pharmaceutical Supply Chain: How to Shrink Upstream Risk Without Shrinking Access

Europe’s pharmaceutical landscape is undergoing a significant change due to…

by

0
Pharma Licensing 2025 and Beyond Rethinking Strategic Partnerships for Long-Term Value
November 10, 2025

Pharma Licensing 2025 and Beyond: Rethinking Strategic Partnerships for Long-Term Value

Introduction: Licensing as a Growth Engine in Pharma The global…

by

0
FDA’s Updated Biosimilar Policy What it really means in the US, EU5, Japan, and China
November 10, 2025

FDA’s Updated Biosimilar Policy: What it really means in the US, EU5, Japan, and China

The regulatory landscape for biosimilars is shifting significantly in 2025.…

by

0
Pharma GCC Setup A Strategic Feasibility Framework for Location and Talent Decisions
November 10, 2025

Pharma GCC Setup: A Strategic Feasibility Framework for Location and Talent Decisions

The pharma industry has seen a wave of change over…

by

0

Need customize support?

Thelansis also caters to your specific needs by providing customized reports that satisfy your organizational requirements. Get on-demand customization of the report’s scope to exactly meet your needs.

Connect with Expert